Meridian Bioscience Stock Fundamentals
| VIVODelisted Stock | USD 33.97 0.00 0.00% |
Meridian Bioscience fundamentals help investors to digest information that contributes to Meridian Bioscience's financial success or failures. It also enables traders to predict the movement of Meridian Stock. The fundamental analysis module provides a way to measure Meridian Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Meridian Bioscience stock.
Meridian |
Meridian Bioscience Company Return On Equity Analysis
Meridian Bioscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Meridian Bioscience Return On Equity | 0.12 |
Most of Meridian Bioscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Meridian Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Meridian Bioscience has a Return On Equity of 0.1219. This is 100.51% lower than that of the Health Care Equipment & Supplies sector and 101.82% lower than that of the Health Care industry. The return on equity for all United States stocks is 139.32% lower than that of the firm.
Meridian Bioscience Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Meridian Bioscience's current stock value. Our valuation model uses many indicators to compare Meridian Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Meridian Bioscience competition to find correlations between indicators driving Meridian Bioscience's intrinsic value. More Info.Meridian Bioscience is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.85 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Meridian Bioscience is roughly 1.18 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Meridian Bioscience's earnings, one of the primary drivers of an investment's value.Meridian Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Meridian Bioscience's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Meridian Bioscience could also be used in its relative valuation, which is a method of valuing Meridian Bioscience by comparing valuation metrics of similar companies.Meridian Bioscience is currently under evaluation in return on equity category among its peers.
Meridian Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 1.39 B | |||
| Shares Outstanding | 43.83 M | |||
| Shares Owned By Insiders | 1.34 % | |||
| Shares Owned By Institutions | 90.92 % | |||
| Number Of Shares Shorted | 4.24 M | |||
| Price To Earning | 19.81 X | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 333.02 M | |||
| Gross Profit | 188.36 M | |||
| EBITDA | 72.02 M | |||
| Net Income | 42.46 M | |||
| Cash And Equivalents | 83.49 M | |||
| Cash Per Share | 1.91 X | |||
| Total Debt | 25 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 3.52 X | |||
| Book Value Per Share | 8.41 X | |||
| Cash Flow From Operations | 82.36 M | |||
| Short Ratio | 7.74 X | |||
| Earnings Per Share | 0.96 X | |||
| Price To Earnings To Growth | 1.33 X | |||
| Target Price | 34.0 | |||
| Number Of Employees | 690 | |||
| Beta | 0.23 | |||
| Market Capitalization | 1.49 B | |||
| Total Asset | 463.1 M | |||
| Retained Earnings | 36.09 M | |||
| Working Capital | 104.22 M | |||
| Current Asset | 126.79 M | |||
| Current Liabilities | 22.57 M | |||
| Z Score | 35.4 | |||
| Five Year Return | 3.78 % | |||
| Net Asset | 463.1 M |
About Meridian Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Meridian Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Meridian Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Meridian Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 702 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |